title: [Hylak Forte drops in the treatment of atopic eczema in children].
abstract: The authors describe a group of 14 children with atopic eczema where to common Hismanal or Zaditen treatment in tablet form Hylak forte drops were added (L. Merckle Co.). After two months treatment the authors observed regression of subjective and objective complaints in 10 children. As to the investigated immunological parameters, they observed normal phagocyte activity of granulocytes and in the majority of children a decline of circulating immune complexes. This creates prerequisite conditions for reducing the costs of treatment and for starting aimed specific hyposensitization.
authors: Odd. klinickej imunológie, Ustav tbc a respiracných chorôb, Bratislava.
authors: F
authors: F
authors: Hrusovská
authors: Z
authors: Z
authors: Blanáriková
authors: M
authors: M
authors: Ondrisová
authors: J
authors: J
authors: Michalicková
mesh_terms: D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009930:Organic Chemicals
chemical_list: D000890:Anti-Infective Agents; C071735:Hylak; D009930:Organic Chemicals
vernacular_title: Hylak forte kvapky v liecbe atopického ekzému u detí.